Volume: 29 Issue: 4

1. Current diagnosis and treatment of common pediatric sleep disorders Page:241—245
2. Risk factors and management strategy of obstructive sleep apnea and hypopnea syndrom in children Page:246—248
3. New therapeutic strategies of obstructive sleep apnea-hypopnea syndrome in children Page:249—251
4. Pediatric hypoventilation syndrome Page:251—254
5. Effects of recombinant fusion protein interleukin-17F/His on expression of immune-related inflammatory factors in mouse model with Streptococcus pneumoniae infection Page:255—260
6. Therapeutic effect of Azithromycin in the combine-sequential therapy for infants with wheezing Page:261—264
7. Effect of inhibiting the phosphorylation of signal transducer and activator of transcription-3 on Th2 cell-mediated airway inflammation and airway remodeling in a mouse model of asthma Page:265—269
8. Comparison of clinical characteristics of severe pertussis and pertussis-like syndrome in children Page:270—273
9. Changes and significances of interleukin-6, interleukin-10 and vascular adhesion molecule-1 in children with obstructive sleep apnea-hypopnea syndrome Page:274—278
10. Clinical significance of interleukin-4, interferon-γ and immunoglobulin E in children with spasmodic Page:286—288
11. Distribution characteristics and clinical significance of specific immunoglobulin E of 29 kinds of food and inhalation allergens in atopic dermatitis children Page:289—294
12. Non-fermenter isolation and drug resistance analysis of clinical specimens from the year of 2010 to 2012 Page:295—298
13. Effect of T cell immunoglobulin domain and mucin domain protein-3 gene interfered by short hairpin RNA on helper T lymphocytes 17 differentiation and proinflammatory capacity in asthmatic mice Page:303—306
14. Effect of 1,25-dihydroxyvitamin D3 on interleukin 17 expression in mice with asthma Page:307—310
15. Progression of diffusion tensor imaging in children with cerebral palsy Page:311—313